SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-22-022219
Filing Date
2022-02-14
Accepted
2022-02-14 12:35:57
Documents
2
Group Members
BRIAN D. GROSSMANPARTNER ASSET MANAGEMENT, LLCPFM HEALTH SCIENCES GP, LLCPFM HEALTHCARE GROWTH EQUITY I GP, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm225765d1_sc13ga.htm SC 13G/A 131035
2 JOINT FILING AGREEMENT tm225765d1_ex99-1.htm EX-99.1 7738
  Complete submission text file 0001104659-22-022219.txt   140575
Mailing Address 475 SANSOME STREET SUITE 1720 SAN FRANCISCO CA 94111
Business Address 475 SANSOME STREET SUITE 1720 SAN FRANCISCO CA 94111 415-281-1022
PFM Health Sciences, LP (Filed by) CIK: 0001442756 (see all company filings)

IRS No.: 262000428 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710
Business Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710 510-982-6030
Caribou Biosciences, Inc. (Subject) CIK: 0001619856 (see all company filings)

IRS No.: 453728228 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92726 | Film No.: 22628172
SIC: 2836 Biological Products, (No Diagnostic Substances)